Supreme Court asked to restore mail-order access to abortion pills
A drugmaker has requested the Supreme Court to reinstate access to abortion pills by mail. This follows a recent ruling that paused such access. (sources: washingtonpost, theguardian, reuters, abcnews, nbcnews)
Danco, the manufacturer of abortion pills, has asked the Supreme Court to intervene and restore mail-order access to these medications. The request comes after a federal court ruling that temporarily blocks this access.
- Danco is seeking a stay on a ruling that pauses mail-order access to abortion drugs.
- The Supreme Court has been asked to halt the ban on telehealth and mail access to these medications.
- The request follows a federal court decision that impacted access to abortion pills.
Why it matters
The outcome could affect the availability of abortion pills through mail-order services.
↓ Why this is on ModernAction
5 bills on this issue are moving right now — and the most active one is To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes..
HR679 · 119th Congress
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Where do you stand on this bill?
Takes about 60 seconds
About this bill
What HR679 actually does
This story is about a request to the Supreme Court to restore mail-order access to abortion pills after a ruling paused that access. This bill would nullify FDA changes to mifepristone dispensing rules by reversing the January 2023 modifications to the REMS program, restoring prior dispensing requirements that affect mail delivery of the drug.
If passed, it would:
- Reverts FDA dispensing rules for mifepristone to pre-2023 standards • Changes whether mifepristone would be mailed by restoring in-person dispensing rules.
4 other bills moving on this issue
Take action on any of them individually.
This story is about Drugmaker asks Supreme Court to restore abortion pill access by mail. This bill would revise federal criminal/import provisions tied to mailing/shipping abortion-related items.
If passed, it would
- Revise federal criminal/import provisions tied to mailing/shipping abortion-related items • Make it harder to use those provisions to justify a nationwide mail-order ban for medication abortion.
This story is about Drugmaker asks Supreme Court to restore abortion pill access by mail. This bill would nullify FDA’s January 2023 modifications to mifepristone dispensing requirements and limit future loosening.
If passed, it would
- Nullify FDA’s January 2023 modifications to mifepristone dispensing requirements and limit future loosening • Add additional conditions tied to enforcement discretion and state reporting (per CRS summary.
This story is about whether people would receive abortion pills by mail after a court paused mail delivery of the drugs. This bill would create statutory rights to obtain FDA-approved medicines and related services, providing a legal basis to challenge government actions that restrict access to approved abortion drugs.
If passed, it would
- Creates statutory rights to obtain FDA-approved medicines • Allows challenges to government actions that limit access to approved drugs.
This story is about Drugmaker asks Supreme Court to restore abortion pill access by mail. This bill would require an in-person exam and physical presence for medication-abortion prescribing/dispensing.
If passed, it would
- Require an in-person exam and physical presence for medication-abortion prescribing/dispensing • Create criminal penalties for providers who don’t comply (patient not prosecuted, per summary.
Top coverage · 13 sources